International Journal of Clinical Case Reports 2024, Vol.14, No.4, 221-229 http://medscipublisher.com/index.php/ijccr 226 essential to maintain a healthy weight and improve overall physical function. Long-term survivors of gastric cancer often report reduced quality of life due to digestive symptoms like dumping syndrome, nausea, and reflux. Ensuring nutritional adequacy and addressing psychological impacts related to altered body image and lifestyle changes are important factors for maintaining a good quality of life (Yu et al., 2016). Figure 3 Funnel plots to assess publication bias for outcomes of association between unspecific postoperative complications and overall survival (Adopted from Li et al., 2019). 7 Future Directions in Gastric Cancer Surgery 7.1 Development of next-generation robotic systems The next generation of robotic systems aims to overcome the limitations of current robotic surgery by enhancing precision, flexibility, and accessibility. These advancements include improved haptic feedback, which allows surgeons to feel the tissue they are manipulating, and enhanced 3D imaging for more precise anatomical visualization. Robotic systems such as the da Vinci platform are being further developed to shorten the learning curve for complex procedures like total gastrectomies, allowing for more consistent and safer surgeries, especially for lymph node dissection (Terashima et al., 2015). There is also growing interest in patient-specific 3D-printed robotic systems, which could tailor surgical tools to each individual patient, optimizing surgical outcomes. 7.2 Role of artificial intelligence in precision surgery Artificial intelligence (AI) is becoming increasingly integrated into surgical procedures, with applications that include decision support, real-time imaging analysis, and personalized surgical planning. AI can process vast amounts of genomic and clinical data to assist surgeons in determining the best surgical approach, identifying tumor boundaries, and predicting potential complications. AI-guided systems are also being developed to assist with surgical navigation and enhance precision, particularly in identifying small lesions or critical anatomical structures during surgery (Jin et al., 2020). The combination of AI and nanotechnology is also being explored for the development of more precise cancer treatments that integrate surgical and therapeutic interventions (Adir et al., 2019). 7.3 Integration of genomic and molecular data in surgical decision-making The field of precision medicine is revolutionizing gastric cancer surgery by incorporating genomic and molecular data to tailor treatments to individual patients. Genomic profiling allows for the identification of specific mutations or biomarkers that can guide decisions regarding the extent of resection and the need for adjuvant therapies (Mihmanlı et al., 2016). Molecular diagnostics also aid in staging and assessing the risk of metastasis, allowing surgeons to plan more targeted and personalized interventions (Wang et al., 2021). In the future, molecular diagnostics could enable real-time adjustments during surgery, improving outcomes and reducing recurrence rates.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==